Viewing nowLipidant Tablets 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

MFDS item code 201404482 · Approved 2014.09.30 · Insurance code 641906150
Reduction of risk of myocardial infarction and stroke, improvement of hyperlipidemia
This medication helps reduce the risk of cardiovascular diseases. Specifically, it is effective in lowering the risk of heart-related complications such as myocardial infarction, stroke, vascular interventions, and angina. It plays a preventive role against various cardiovascular disease risk factors even in diabetic patients or high-risk adults. It also effectively lowers total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels in patients with hyperlipidemia, thereby improving vascular health. It can be used together with dietary changes in pediatric patients with familial hypercholesterolemia. Therefore, this medication is used to maintain cardiovascular health and reduce the risk of various related diseases.
Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily, but for patients requiring more LDL cholesterol reduction, the starting dose can be 20 mg or 40 mg once daily. Dosage range is from 10 mg to 80 mg once daily, and it should be individualized based on treatment goals and patient characteristics; lipid levels should be analyzed within 2-4 weeks after starting or adjusting the dose. The treatment goal is to reduce LDL cholesterol levels; therefore, it is recommended to monitor LDL cholesterol levels during the initiation of treatment and evaluation of treatment response. However, if LDL cholesterol levels cannot be monitored, total cholesterol levels may be used for assessing treatment response.
For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17): The recommended initial dose is 10 mg once daily, with a maximum dose of 20 mg once daily. Dosage should be adjusted at intervals of 4 weeks or more according to treatment goals.
This medication can cause muscle-related side effects; therefore, if severe muscle pain or weakness occurs, or if there is a significant rise in creatine kinase levels, treatment should be stopped immediately. This medication should not be administered to patients with severe liver dysfunction or active liver disease, and patients with any signs of liver dysfunction should undergo regular liver function tests. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Children, especially those under 10 years old, should not be given this medication. Caution is required for patients with reduced kidney function or the elderly due to increased risk of myopathy and rhabdomyolysis; these patients should have regular assessments of muscle condition and blood tests. This medication may increase blood concentration when taken with certain antibiotics, antifungals, and antivirals, so it is essential to consult a physician or pharmacist. If symptoms such as muscle pain, fatigue, or fever occur during treatment, immediate notification of healthcare professionals is necessary, and blood tests may be required to check for muscle damage. This medication may increase blood levels when taken with grapefruit juice, so it is recommended to avoid grapefruit juice consumption. This medication contains lactose; therefore, patients with lactose intolerance should consult with healthcare professionals before taking it. Regular liver function tests and muscle-related tests are recommended during treatment, and if any abnormal symptoms arise, treatment should be stopped immediately and consult healthcare providers.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory distress with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden severe headache, thunderclap headache, seizures, confusion, vision abnormalities, paralysis, urination problems
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that prevents air and moisture exposure, and it is crucial to keep it at a temperature between 1°C and 30°C. This storage will maintain the effectiveness of the medication and prevent degradation.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.